Federal court: CBD drugmaker GW Pharmaceuticals didn’t violate extraction patent -

A Texas court has dismissed a lawsuit accusing pharmaceutical CBD maker GW Pharmaceuticals of violating another company’s patented method of cannabidiol extraction for its epilepsy drug Epidiolex,

Federal court: CBD drugmaker GW Pharmaceuticals didn’t violate extraction patent is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs